Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1258 Clinical and demographic factors associated with immune related adverse events among those treated with immune checkpoint inhibitors
Compose a Response to This Article
Other responses
No responses have been published for this article.
